Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
The main objective of this paper is to make available in a single document, a sequence of events that have been published on the biology of malaria parasites and their interaction with the human host, looking for arguments for effective and save treatment: what we know and what we would like to know...
Main Author: | López-Antuñano Francisco Javier |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Nacional de Salud Pública
1999-01-01
|
Series: | Salud Pública de México |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341999000500010 |
Similar Items
-
Primaquine in vivax malaria: an update and review on management issues
by: Fernando Deepika, et al.
Published: (2011-12-01) -
Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon
by: Wilson M Ramos Júnior, et al. -
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
by: Parinaz Mehdipour, et al.
Published: (2023-10-01) -
Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India
by: Manju Rahi, et al.
Published: (2023-06-01) -
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Agus Setyadi, et al.
Published: (2019-04-01)